Matthew Goff Investment Advisor, LLC Novartis Ag Transaction History

Matthew Goff Investment Advisor, LLC

  • $486 Million
  • Q2 2024

A detailed history of Matthew Goff Investment Advisor, LLC transactions in Novartis Ag stock. As of the latest transaction made, Matthew Goff Investment Advisor, LLC holds 87,903 shares of NVS stock, worth $10.2 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
87,903
Previous 84,583 3.93%
Holding current value
$10.2 Million
Previous $8.18 Million 14.39%
% of portfolio
1.92%
Previous 1.66%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024
BUY
$92.57 - $107.37 $307,332 - $356,468
3,320 Added 3.93%
87,903 $9.36 Million
Q1 2024

Apr 11, 2024
BUY
$95.27 - $108.47 $155,385 - $176,914
1,631 Added 1.97%
84,583 $8.18 Million
Q4 2023

Jan 09, 2024
SELL
$92.27 - $101.54 $52,593 - $57,877
-570 Reduced 0.68%
82,952 $8.38 Million
Q3 2023

Oct 10, 2023
SELL
$94.73 - $105.13 $14,304 - $15,874
-151 Reduced 0.18%
83,522 $8.51 Million
Q2 2023

Jul 12, 2023
BUY
$92.52 - $104.91 $139,520 - $158,204
1,508 Added 1.84%
83,673 $8.44 Million
Q1 2023

Apr 13, 2023
SELL
$80.03 - $92.81 $27,130 - $31,462
-339 Reduced 0.41%
82,165 $7.56 Million
Q4 2022

Jan 11, 2023
BUY
$75.55 - $92.52 $46,538 - $56,992
616 Added 0.75%
82,504 $0
Q3 2022

Oct 13, 2022
BUY
$74.61 - $87.26 $132,358 - $154,799
1,774 Added 2.21%
81,888 $6.22 Million
Q2 2022

Jul 22, 2022
BUY
$80.52 - $93.75 $763,812 - $889,312
9,486 Added 13.43%
80,114 $6.77 Million
Q1 2022

Apr 19, 2022
BUY
$80.11 - $90.62 $800,539 - $905,565
9,993 Added 16.48%
70,628 $6.2 Million
Q4 2021

Jan 18, 2022
BUY
$79.7 - $88.13 $54,993 - $60,809
690 Added 1.15%
60,635 $5.3 Million
Q3 2021

Oct 12, 2021
BUY
$81.78 - $95.14 $191,283 - $222,532
2,339 Added 4.06%
59,945 $4.9 Million
Q2 2021

Jul 22, 2021
BUY
$85.24 - $94.15 $320,843 - $354,380
3,764 Added 6.99%
57,606 $5.26 Million
Q1 2021

Apr 21, 2021
SELL
$83.5 - $98.47 $30,227 - $35,646
-362 Reduced 0.67%
53,842 $4.6 Million
Q4 2020

Jan 27, 2021
BUY
$78.07 - $94.43 $300,179 - $363,083
3,845 Added 7.64%
54,204 $5.12 Million
Q3 2020

Oct 29, 2020
BUY
$82.14 - $91.0 $119,349 - $132,223
1,453 Added 2.97%
50,359 $4.38 Million
Q2 2020

Jul 31, 2020
BUY
$80.93 - $91.1 $65,877 - $74,155
814 Added 1.69%
48,906 $4.27 Million
Q1 2020

May 05, 2020
BUY
$70.67 - $99.01 $515,113 - $721,683
7,289 Added 17.86%
48,092 $3.97 Million
Q4 2019

Jan 27, 2020
SELL
$84.35 - $95.37 $17,797 - $20,123
-211 Reduced 0.51%
40,803 $3.86 Million
Q3 2019

Nov 07, 2019
BUY
$85.54 - $94.26 $3.2 Million - $3.53 Million
37,450 Added 1050.79%
41,014 $3.56 Million
Q3 2019

Oct 29, 2019
SELL
$85.54 - $94.26 $3.19 Million - $3.52 Million
-37,330 Reduced 91.28%
3,564 $309,000
Q2 2019

Aug 05, 2019
SELL
$75.4 - $92.8 $27,370 - $33,686
-363 Reduced 0.88%
40,894 $3.73 Million
Q1 2019

May 13, 2019
BUY
$75.32 - $86.15 $37,208 - $42,558
494 Added 1.21%
41,257 $3.97 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $59,369 - $66,108
806 Added 2.02%
40,763 $3.5 Million
Q3 2018

Dec 06, 2018
BUY
$66.94 - $77.43 $64,864 - $75,029
969 Added 2.49%
39,957 $3.44 Million
Q3 2018

Nov 21, 2018
SELL
$66.94 - $77.43 $195 Million - $225 Million
-2,906,190 Reduced 98.68%
38,988 $2.95 Million
Q3 2018

Nov 15, 2018
BUY
$66.94 - $77.43 $195 Million - $225 Million
2,906,190 Added 7454.06%
2,945,178 $39 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $640,856 - $724,283
9,873 Added 33.91%
38,988 $2.95 Million
Q1 2018

May 10, 2018
BUY
$70.39 - $84.15 $113,961 - $136,238
1,619 Added 5.89%
29,115 $2.35 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $106,180 - $113,975
1,468 Added 5.64%
27,496 $2.31 Million
Q3 2017

Nov 08, 2017
BUY
$74.14 - $77.27 $186,981 - $194,874
2,522 Added 10.73%
26,028 $2.24 Million
Q2 2017

Aug 10, 2017
BUY
N/A
23,506
23,506 $1.96 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Matthew Goff Investment Advisor, LLC Portfolio

Follow Matthew Goff Investment Advisor, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthew Goff Investment Advisor, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthew Goff Investment Advisor, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email